ATE20748T1 - Guaninderivate. - Google Patents

Guaninderivate.

Info

Publication number
ATE20748T1
ATE20748T1 AT81850250T AT81850250T ATE20748T1 AT E20748 T1 ATE20748 T1 AT E20748T1 AT 81850250 T AT81850250 T AT 81850250T AT 81850250 T AT81850250 T AT 81850250T AT E20748 T1 ATE20748 T1 AT E20748T1
Authority
AT
Austria
Prior art keywords
fluoro
hydroxy
hydrogen
methods
different
Prior art date
Application number
AT81850250T
Other languages
English (en)
Inventor
Curt-Erik Hagberg
Karl Nils-Gunnar Johansson
Zsuzsanna Maria Ilona Kovacs
Goeran Bertil Stening
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Application granted granted Critical
Publication of ATE20748T1 publication Critical patent/ATE20748T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT81850250T 1980-12-22 1981-12-22 Guaninderivate. ATE20748T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8009040 1980-12-22
EP81850250A EP0055239B1 (de) 1980-12-22 1981-12-22 Guaninderivate

Publications (1)

Publication Number Publication Date
ATE20748T1 true ATE20748T1 (de) 1986-08-15

Family

ID=20342543

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81850250T ATE20748T1 (de) 1980-12-22 1981-12-22 Guaninderivate.

Country Status (17)

Country Link
US (1) US4495190A (de)
EP (1) EP0055239B1 (de)
JP (1) JPS57501963A (de)
AT (1) ATE20748T1 (de)
AU (1) AU542373B2 (de)
CA (1) CA1172633A (de)
DE (1) DE3174948D1 (de)
DK (1) DK148279C (de)
FI (1) FI68054C (de)
GR (1) GR76971B (de)
IL (1) IL64501A (de)
NO (1) NO822712L (de)
NZ (1) NZ199334A (de)
RO (1) RO85288B (de)
SU (2) SU1272991A3 (de)
WO (1) WO1982002202A1 (de)
ZA (1) ZA818781B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
US4801710A (en) * 1984-10-26 1989-01-31 Merck & Co., Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
YU45690B (sh) * 1984-12-22 1992-07-20 Krka Tovarna Zdraviln.Sol.O. Postopek za pripravo 9-(2-hidroksietoksimetil)-gvanina
EP0193454A1 (de) * 1985-02-25 1986-09-03 Merck & Co. Inc. 8-Substituierte-9-Hydroxyalkyl- und -Hydroxyalkoxymethylguanine und sie enthaltende pharmazeutische Zusammensetzungen
EP0219838A3 (de) * 1985-10-22 1988-04-06 Takeda Chemical Industries, Ltd. Carbocyclische Purin-Nukleoside, ihre Herstellung und Verwendung
US5578468A (en) * 1987-08-10 1996-11-26 Duke University Site-specific RNA cleavage
US5443964A (en) * 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
US4935427A (en) * 1987-12-31 1990-06-19 The United States Of America As Represented By The Department Of Health And Human Services Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
US5352669A (en) * 1990-03-13 1994-10-04 The Of The United States Of America As Represented By The Department Of Health And Human Services O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
CZ285420B6 (cs) * 1990-04-24 1999-08-11 Ústav Organické Chemie A Biochemie Avčr N-(3-Fluor-2-fosfonylmethoxypropyl)deriváty purinových a pyrimidinových heterocyklických bazí, způsoby jejich přípravy a použití
US5368853A (en) * 1990-05-11 1994-11-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Leukoregulin anti-viral therapy
JP2939646B2 (ja) * 1990-07-17 1999-08-25 チッソ株式会社 ４―置換―２―ヒドロキシブタン酸エステルおよび製造法
US5874578A (en) * 1992-07-13 1999-02-23 Bristol-Myers Squibb Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process
US5525606A (en) 1994-08-01 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
US6359114B1 (en) 1995-06-07 2002-03-19 Aphton Corp. System for method for the modification and purification of proteins
US6060458A (en) * 1998-02-13 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxyribonucleotides comprising O6 -benzylguanine and their use
AU2002343604C1 (en) 2001-10-30 2009-09-17 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
NZ546611A (en) 2003-09-18 2010-02-26 Conforma Therapeutics Corp Novel heterocyclic compounds as HSP90-inhibitors
WO2006105372A2 (en) 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
JP4966969B2 (ja) * 2005-06-14 2012-07-04 ブリガム ヤング ユニバーシティ プリンの選択的ｎ−９グリコシル化のための方法
EP1937258A2 (de) * 2005-09-23 2008-07-02 Conforma Therapeutics Corporation Antitumorale verfahren mit multi-arzneiresistenz-unabhägnigen synthetischen hsp90-hemmern
CN108912055B (zh) * 2018-08-20 2020-06-30 河南师范大学 一种合成抗病毒药物西多福韦中间体和布昔洛韦中间体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34188A (en) * 1969-04-09 1972-12-29 Seiyaku T Co 4-(9-adenyl)-2,3-dihydroxy butyric acid and the preparation thereof
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
CS199093B1 (en) * 1977-10-20 1980-07-31 Antonin Holy Antiviral agent
US4230708A (en) * 1977-10-20 1980-10-28 Stichting Rega V.Z.W. Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds

Also Published As

Publication number Publication date
EP0055239A1 (de) 1982-06-30
AU7872181A (en) 1982-07-01
GR76971B (de) 1984-09-04
RO85288A (ro) 1984-11-25
WO1982002202A1 (en) 1982-07-08
ZA818781B (en) 1982-11-24
SU1272991A3 (ru) 1986-11-23
SU1272992A3 (ru) 1986-11-23
FI68054C (fi) 1985-07-10
CA1172633A (en) 1984-08-14
DK148279C (da) 1986-02-17
AU542373B2 (en) 1985-02-21
FI822891L (fi) 1982-08-19
DK148279B (da) 1985-05-28
EP0055239B1 (de) 1986-07-16
US4495190A (en) 1985-01-22
FI822891A0 (fi) 1982-08-19
DE3174948D1 (en) 1986-08-21
FI68054B (fi) 1985-03-29
NZ199334A (en) 1985-09-13
JPS57501963A (de) 1982-11-04
IL64501A (en) 1985-07-31
IL64501A0 (en) 1982-03-31
DK369982A (da) 1982-08-18
RO85288B (ro) 1984-11-30
NO822712L (no) 1982-08-09

Similar Documents

Publication Publication Date Title
ATE20748T1 (de) Guaninderivate.
FR2385722A1 (fr) Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2358406A1 (fr) Derives d'acides 5-aroyl-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrole-1-carboxyliques, leur obtention et leur application a titre de medicament
FR2422405A1 (fr) Nouveaux medicaments constitues de derives de l'acide p-aminobenzoique
FI863565A0 (fi) Foerfarande foer framstaellning av nya pyrrobenzimidazoler, pyrrolbenzoxazoler och pyrrolbenztiazoler.
AU1706083A (en) Novel derivatives of guanine i
ATE13423T1 (de) Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen.
ES516158A0 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
ATE19632T1 (de) Guanin-derivate.
FR2386547A1 (fr) Nouveaux derives de la pyrido-(2,3-b)benzothiazepine-(1,5) substitues en position 5, leur procede de preparation et leur application pharmaceutique
FR2421616A1 (fr) Nouveaux medicaments constitues de derives de l'acide o-aminobenzoique
FR2430230A1 (fr) Medicaments a base de derives de l'acide anthranilique
SE8206128L (sv) Farmaceutisk komposition for behandling av njurstenar framkallade genom infektion
ES8302673A1 (es) Procedimiento para la preparacion de un 5-feniltetrazol
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
FR2384742A1 (fr) Nouvelles diphenyl cycloalkylamines, procede d'obtention et application a titre de medicament
ES8308335A1 (es) Un procedimiento para la preparacion de nuevos derivados de desoxiuridina.
SE8202433L (sv) Linkomycin-3-(5'-ribonukleotider)lempade for behandling av protosoriska sjukdomar
FR2390956A1 (fr) Derives substitues de la quinolizidine et de l'indolizidine, leur procede de preparation et agents therapeutiques contenant lesdits derives
NO159277C (no) 2,6-bis-halogenacylamino-benzo(1,2-d:5,4-d[)-bistiazol-derivater egnet som mellomprodukter for fremstilling av terapeutisk aktive 2,6-bisaminobinzo-(1,2-d:5,4-d[)bistiazol-derivater.
FR2368484A2 (fr) Nouveaux derives de la benzol(5,6)gamma-pyrone, leur procede de preparation et leur utilisation therapeutique
FR2401923A1 (fr) Nouvelles octahydropyrazinopyrimidinones 2,3,4,7,8,9-substituees, procede de preparation de ces derives et leur application en tant que medicaments

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties